Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McMaster University

$43,000.00

Natural products: biosynthesis, biomimetic synthesis and mechanism of action

FY 2008-09

Summary
Natural products have an enormous impact on all of our lives: they include, or form the basis of, many of the antibiotics, cholesterol-lowering statins, immunosuppressants, and other therapeutic agents in use today. Our research program aims to understand how these small organic compounds are made by the producing organisms, be they bacteria, fungi, or plants. Knowledge of the assembly of these metabolites in vivo aids not only in the control of pharmaceutical production, but also holds promise for creating new structures not found before in nature: these have potential as the drugs of tomorrow. Another important aspect of generating novel chemical entities as potential drugs is to explore their chemical synthesis. Our program aims to learn from the natural assembly process how to perform more effective chemistry. Thus, we have developed a novel method that allows the fatty acid and polyketide classes of natural products to be assembled in the test tube by following the same sequence of events that occurs in nature. We are developing this method for the general synthesis of polyketide structures. In another area, we are mimicking the natural formation of beta-lactone natural products; these are relatives of the penicillin antibiotics. A third aspect of natural products that is also being explored in our lab is the mode of action of these compounds. We are exploring how two classes of compound work; understanding this mechanism of action will allow the development of better drugs. One class of compound induces apoptosis, i.e. programmed cell death, an area of enormous interest in cancer chemotherapy. The other class, the beta-lactones, is being investigated as novel anti-fungal agents; there is a great need for improved anti-fungal drugs due to the development of drug-resistant fungal strains. Our collaborator at McMaster has identified a novel cellular target for attack, a promising result since resistance is rare when new cellular pathways are targeted. We are providing the natural products and analogues to inactivate this target.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
92423-2007
Name nom
Harrison, Paul
Department département
Chemistry
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2007
Award amount
43000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3701
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Natural products
Research subject fr
Produits naturels
Partie
2
Nb partie
5
Application title
Natural products: biosynthesis, biomimetic synthesis and mechanism of action
Keyword
NA
Application summary
Natural products have an enormous impact on all of our lives: they include, or form the basis of, many of the antibiotics, cholesterol-lowering statins, immunosuppressants, and other therapeutic agents in use today. Our research program aims to understand how these small organic compounds are made by the producing organisms, be they bacteria, fungi, or plants. Knowledge of the assembly of these metabolites in vivo aids not only in the control of pharmaceutical production, but also holds promise for creating new structures not found before in nature: these have potential as the drugs of tomorrow. Another important aspect of generating novel chemical entities as potential drugs is to explore their chemical synthesis. Our program aims to learn from the natural assembly process how to perform more effective chemistry. Thus, we have developed a novel method that allows the fatty acid and polyketide classes of natural products to be assembled in the test tube by following the same sequence of events that occurs in nature. We are developing this method for the general synthesis of polyketide structures. In another area, we are mimicking the natural formation of beta-lactone natural products; these are relatives of the penicillin antibiotics. A third aspect of natural products that is also being explored in our lab is the mode of action of these compounds. We are exploring how two classes of compound work; understanding this mechanism of action will allow the development of better drugs. One class of compound induces apoptosis, i.e. programmed cell death, an area of enormous interest in cancer chemotherapy. The other class, the beta-lactones, is being investigated as novel anti-fungal agents; there is a great need for improved anti-fungal drugs due to the development of drug-resistant fungal strains. Our collaborator at McMaster has identified a novel cellular target for attack, a promising result since resistance is rare when new cellular pathways are targeted. We are providing the natural products and analogues to inactivate this target.